Investors

  • 2020-10-27VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON THE COMPLETION OF PHASE 3 BRIDGING CLINICAL TRIAL OF XERAVATM (ERAVACYCLINE) FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN CHINA
  • 自愿公告 最新业务情况有关完成依拉环素用于治疗 复杂性腹腔内感染的Xerava TM(依拉环素, eravacycline)3 期桥接临床试验
  • 2020-10-08ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
  • 发售价及配发结果公告

    
 

 Copyright Everest Medicines 2020   苏ICP备20038571号 |  Terms of Use |  Privacy Policy |  Disclaimers